ABOUT CELL & GENE COLLABORATIVE

At Life Science Connect, we’re passionate about the nascent cell and gene therapy industry and want to do our part to help these challenging and innovative programs come to market. This will require cross-company and industry communication and a better understanding of the quickly evolving regulatory and manufacturing landscape.

Cell & Gene Collaborative is an invite-only peer group, the members of which are responsible for making the manufacturing and outsourcing decisions at companies developing cell and gene therapies. Cell & Gene Collaborative is your portal to cross-company and industry dialogue, thought leadership, and networking opportunities to confront your greatest technical- and business-related cell and gene therapy manufacturing and outsourcing challenges.

Cell & Gene Collaborative is part of Life Science Collaborative, which is part of the Life Science Connect network of products and services for life science professionals.

AUTHORITY

Anna Rose Welch, Director

Anna Rose Welch is the director of Cell & Gene Collaborative. In this role, she is forging close relationships with the leading voices and organizations in the cell and gene therapy manufacturing sphere. This includes establishing a peer group comprising C&G company manufacturing SMEs, conducting interviews and hosting interactive roundtables on the evolving manufacturing paradigm, and authoring thought leadership articles and blog posts via the C&G Collaborative blog.

Prior to launching Cell & Gene Collaborative, Anna Rose spent five years building an extensive network and editorial following as the Chief Editor of Biosimilar Development. In addition to penning thought leadership on biosimilar regulatory affairs, government policy, and commercialization advances, she was also an active participant in the biosimilar conferences circuit. She was appointed chair or served as a speaker and panel moderator at international conferences, including the World Biosimilar Congress USA, The Biotech Pharma Summit (EU), the CBI Biosimilars Summit, DIA Biosimilars Conference, and the Biosimilar Medicines Group Conference (EU). In 2018, she was invited to Brazil where she addressed members of the Brazilian Ministry of Health, ANVISA, and local biologics and biosimilar manufacturers on establishing national biologics and biosimilar policies. She also represented the publication on a media tour of Bangkok, Thailand in 2017, during which she reported on the country’s efforts to bolster its life sciences industry. In addition to writing for Biosimilar Development, she penned the introductory chapter to the book, Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development (Springer, 2018).

In 2018, her first book of poetry, We, The Almighty Fires, was published by Alice James Books.

CONTACT CELL & GENE COLLABORATIVE

Cell & Gene Collaborative is a product of Life Science Connect, a division of VertMarkets.

• Learn more about Cell & Gene Collaborative
• Join Cell & Gene Collaborative
• Email general questions

Office Locations